Form 4 Filing for C4 Therapeutics, Inc.

This Form 4 filing details a derivative transaction by Steven L. Hoerter, a director at C4 Therapeutics, Inc. (CCCC). On June 24, 2026, Mr. Hoerter was granted 62,000 stock options with an exercise price of $4.25 per share. These options are set to vest and become exercisable on June 24, 2027, or the next annual stockholder meeting, whichever occurs first, provided Mr. Hoerter remains on the Board. The options expire on June 23, 2036. The transaction code "A" indicates an acquisition, and the ownership nature is direct. Following this transaction, Mr. Hoerter holds 62,000 shares of common stock underlying these options.